CA2138644A1 - Methode de traitement des troubles oculaires a l'aide de tgf-¨ - Google Patents
Methode de traitement des troubles oculaires a l'aide de tgf-¨Info
- Publication number
- CA2138644A1 CA2138644A1 CA002138644A CA2138644A CA2138644A1 CA 2138644 A1 CA2138644 A1 CA 2138644A1 CA 002138644 A CA002138644 A CA 002138644A CA 2138644 A CA2138644 A CA 2138644A CA 2138644 A1 CA2138644 A1 CA 2138644A1
- Authority
- CA
- Canada
- Prior art keywords
- tgf
- beta
- retinal
- neovascularization
- ocular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91083492A | 1992-07-08 | 1992-07-08 | |
US877893A | 1993-01-22 | 1993-01-22 | |
US07/910,834 | 1993-01-22 | ||
US08/008,778 | 1993-01-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2138644A1 true CA2138644A1 (fr) | 1994-01-20 |
Family
ID=26678611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002138644A Abandoned CA2138644A1 (fr) | 1992-07-08 | 1993-07-08 | Methode de traitement des troubles oculaires a l'aide de tgf-¨ |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0651650A4 (fr) |
JP (1) | JPH08502033A (fr) |
AU (1) | AU4668193A (fr) |
CA (1) | CA2138644A1 (fr) |
WO (1) | WO1994001124A1 (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5688765A (en) * | 1992-04-21 | 1997-11-18 | The Schepens Eye Research Institute, Inc. | Ocular therapy in Sjogren's syndrome using topically applied androgensor TGF-β |
WO1995009004A1 (fr) * | 1993-09-29 | 1995-04-06 | Alcon Laboratories, Inc. | Compositions contenant des facteurs de croissance et des agents antiplastiques |
US5449671A (en) * | 1993-09-29 | 1995-09-12 | Alcon Laboratories, Inc. | Use of TGF-β3, to prevent or retard fistula closure following glaucoma filtration surgery |
CA2149528A1 (fr) * | 1993-09-29 | 1995-04-06 | Billie M. York | Compositions contenant des facteurs de croissance et des antimetabolites |
US5411940A (en) * | 1993-09-29 | 1995-05-02 | Alcon Laboratories, Inc. | Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma |
JPH09505057A (ja) * | 1993-11-19 | 1997-05-20 | ザ・ユニバーシティ・オブ・シドニー | 白内障を予防または制御するための方法 |
AU688409B2 (en) * | 1993-11-19 | 1998-03-12 | University Of Sydney, The | A method for preventing or controlling cataract |
WO2001009327A2 (fr) * | 1999-07-28 | 2001-02-08 | Genentech, Inc. | Procede de prevention de la deterioration ou de la mort des cellules de la retine et de traitement des troubles oculaires |
US5827702A (en) * | 1994-10-31 | 1998-10-27 | Genentech, Inc. | Ocular gene therapy |
WO2000053760A2 (fr) * | 1999-03-12 | 2000-09-14 | Genentech, Inc. | Technique permettant de prevenir la mort des neurones retiniens et traitement des maladies oculaires |
WO1998024468A1 (fr) * | 1996-12-04 | 1998-06-11 | Clark Abbot F | TGFα UTILISE POUR LE TRAITEMENT DE L'HYPERTENSION OCULAIRE ET DU GLAUCOME |
US6750052B1 (en) | 1997-07-23 | 2004-06-15 | The Brigham And Women's Hospital, Inc. | Lens epithelial cell derived growth factor |
WO1999005278A1 (fr) * | 1997-07-23 | 1999-02-04 | Brigham & Women's Hospital, Inc. | Facteur de croissance des cellules epitheliales derive du cristallin |
US6331523B1 (en) | 1998-03-12 | 2001-12-18 | Genentech, Inc. | Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5 |
DE69912304T2 (de) * | 1998-11-23 | 2004-07-22 | Novartis Ag | Verwendung von staurosporine derivaten zur behandlung von okularen neovaskularen erkrankungen |
WO2001056606A1 (fr) * | 2000-01-31 | 2001-08-09 | Santen Pharmaceutical Co., Ltd. | Remedes pour troubles ophtalmiques |
US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
US8197435B2 (en) | 2006-05-02 | 2012-06-12 | Emory University | Methods and devices for drug delivery to ocular tissue using microneedle |
EA034963B1 (ru) | 2012-11-08 | 2020-04-13 | Клиасайд Байомедикал, Инк. | Способ лечения расстройства заднего сегмента глаза |
SG10201702674PA (en) | 2013-05-03 | 2017-06-29 | Clearside Biomedical Inc | Apparatus and methods for ocular injection |
RU2540504C1 (ru) * | 2013-12-26 | 2015-02-10 | Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации | Способ прогнозирования риска развития поздней отслойки сетчатки у детей с рубцовой ретинопатией недоношенных |
WO2015142855A1 (fr) * | 2014-03-17 | 2015-09-24 | University Of Virginia Patent Foundation | Compositions et méthodes destinées à traiter la rétinopathie |
US9844556B2 (en) | 2015-03-25 | 2017-12-19 | Megumi Honjo | Preventive/therapeutic method and preventive/therapeutic agent for complications after cataract surgery |
WO2017139375A1 (fr) | 2016-02-10 | 2017-08-17 | Clearside Biomedical, Inc. | Kit d'injection oculaire, conditionnement et procédés d'utilisation |
EP3452165A1 (fr) | 2016-05-02 | 2019-03-13 | Clearside Biomedical, Inc. | Systèmes et méthodes pour l'administration de médicaments par voie ophtalmique |
EP3496680A1 (fr) | 2016-08-12 | 2019-06-19 | Clearside Biomedical, Inc. | Dispositifs et procédés de réglage de la profondeur d'insertion d'une aiguille pour administration de médicament |
CN111803623B (zh) * | 2020-07-31 | 2024-07-02 | 重庆康视美科技有限公司 | 一种治疗近视的生物制剂及其制备方法、使用方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8532691A (en) * | 1990-08-01 | 1992-03-02 | Chiron Ophthalmics Inc. | Method for treating corneal endothelial wounds |
-
1993
- 1993-07-08 AU AU46681/93A patent/AU4668193A/en not_active Abandoned
- 1993-07-08 EP EP93917021A patent/EP0651650A4/fr not_active Ceased
- 1993-07-08 CA CA002138644A patent/CA2138644A1/fr not_active Abandoned
- 1993-07-08 WO PCT/US1993/006420 patent/WO1994001124A1/fr not_active Application Discontinuation
- 1993-07-08 JP JP6503502A patent/JPH08502033A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU4668193A (en) | 1994-01-31 |
EP0651650A1 (fr) | 1995-05-10 |
WO1994001124A1 (fr) | 1994-01-20 |
JPH08502033A (ja) | 1996-03-05 |
EP0651650A4 (fr) | 1996-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5767079A (en) | Method of treating ophthalmic disorders using TGF -β | |
CA2138644A1 (fr) | Methode de traitement des troubles oculaires a l'aide de tgf-¨ | |
Glaser et al. | Transforming growth factor-β2 for the treatment of full-thickness macular holes: a prospective randomized study | |
Nuyts et al. | Histopathologic effects of mitomycin C after trabeculectomy in human glaucomatous eyes with persistent hypotony | |
Shields et al. | Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C | |
Mermoud et al. | Surgical management of post-traumatic angle recession glaucoma | |
RU2674148C2 (ru) | Ускоренное заживление повреждений глаз с помощью ангиотензиновых пептидов | |
CN102633863B (zh) | 抗分泌因子对于治疗高眼压的应用 | |
WO1996009838A1 (fr) | PROCEDE DE TRAITEMENT DE LA DEGENERESCENCE MACULAIRE AU MOYEN DE TGF-$g(b) | |
US6124259A (en) | Method for treating ophthalmic disorders with IGFBP | |
Ruparelia et al. | Multiple XEN gel stents for refractory pediatric glaucoma | |
Buxton et al. | Results of penetrating keratoplasty in the iridocorneal endothelial syndrome | |
JPH08503968A (ja) | 増殖因子と代謝拮抗物質を含有する組成物 | |
KR20010012787A (ko) | 안질환 치료에서 초자체액의 액화를 위한 안과용 제제의제조에 있어서의 히알루로니다제의 용도 | |
Shingleton et al. | Combined phacoemulsification, intraocular lens implantation, and trabeculectomy with a modified scleral tunnel and single-stitch closure | |
Bruno et al. | Subconjunctival placement of human amniotic membrane during high risk glaucoma filtration surgery | |
Glasser et al. | Necrotizing scleritis of scleral flaps after transscleral suture fixation of an intraocular lens | |
RU2730975C1 (ru) | Способ лечения эндотелиально-эпителиальной дистрофии роговицы | |
Carlson et al. | Reduced vision secondary to pigmented cellular membranes on silicone intraocular lenses | |
GOLDBERG | Management of uncontrolled glaucoma with the Molteno system | |
Kang et al. | Phacoemulsification and posterior chamber intraocular lens implantation in uveitis. | |
Takahashi et al. | Antiproliferative effect of retinoic acid in 1% sodium hyaluronate in an animal model of PVR | |
Kitazawa et al. | Surgery for refractory glaucoma | |
Mandal | Endocapsular surgery and capsular bag fixation of intraocular lenses in phacolytic glaucoma | |
Egrilmez et al. | Glaucoma implant surgery with autogenous fascia lata in scleromalacia perforans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |